Connect your AI

Organon OGN Accounts Receivable

Accounts Receivable at other companies

PfizerPFE

$12.59B+6.2%

AmgenAMGN

$9.14B+12.4%

The Cooper Companies, Inc.COO

$809.2M+3.6%

AbbVieABBV

$12.48B0.0%

Amneal Pharmaceuticals, Inc.AMRX

-$44.01M-108%

Envista Holdings CorporationNVST

$436.6M+11.1%

Other financials

Income statement

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

Market cap$3.53B-59.4%

Profitability

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Organon's accounts receivable?: Organon (OGN) reported accounts receivable of $1.38B in Q1 2026.
How has Organon's accounts receivable changed year-over-year?: Organon's accounts receivable decreased by 5.0% year-over-year, from $1.46B to $1.38B.
What is the long-term trend for Organon's accounts receivable?: Over 4 years (2021 to 2025), Organon's accounts receivable has grown at a 1.6% compound annual growth rate (CAGR), from $5.4B to $5.76B.
What does accounts receivable mean?: Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.